Umerox Inhal

Umerox Inhal is an individual device designed for inhalation use of methoxyflurane.

Low-dose methoxyflurane provide analgesia.

According to the ATС classification, methoxyflurane is an analgesic (N02BG09).

Active Ingredient:

• methoxyflurane 99%

Dossage form:

• vapors for inhalation, liquid, 2 ml

Indications for the use of methoxyflurane:

• Emergency pain relief in hemodynamically stable patients with trauma and associated pain who are conscious, by self-administration under the supervision of trained personnel.
• Pain relief in conscious patients who are under observation and require analgesia during surgical procedures such as dressing changes.

More about Methoxyflurane

Inhalational analgesic methoxyflurane, which is used with the device Umerox Inhal, provides:

• rapid onset of analgesic effect (1);
• reducing the level of anxiety (2);
• painless, atraumatic administration – no injections, no needles;
• the patient is conscious and controls the degree of analgesia (3);
• non-opioid (1);
• does not require control of the respiratory and cardiovascular system during use (4).

In accordance with the Order of the Ministry of Health of Ukraine No. 1122 dated June 28, 2022. Methoxyflurane is included in the “Methodical recommendations for analgesia of victims during evacuation stages”. Methodological recommendations regulate the provision of assistance by emergency medical aid teams at the pre-hospital stage and at the early hospital stage in health care institutions.

Umerox Inhal is intended for independent use under supervision, or if necessary, with the help of a specialist who has the appropriate experience and medical education, and also knows the technique of using this device.

1. Remove the button from the device.

2. Completely remove the cap (two parts) from the methoxyflurane syringe so that its conical base is visible. After that, install it in the Umerox Inhal, with the conical tip down.

3. Install the button along the grooves in the initial position. Push the top button with your thumb all the way to inject the inhalation liquid into the device.

4. Before using the device, make light oscillating (circular) movements for better distribution and evaporation of the medicine.

5. Attach the mouthpiece to the device’s outlet and place the nose clip on the patient’s nose to prevent nasal breathing.

The device is ready for use.

The patient should start inhalation 5 minutes before the start of the manipulation and continue during its implementation.

The patient should take the first 2-3 breaths shallowly, after which the patient should take breaths as usual. Exhalation should be done exclusively through the mouthpiece inside the device, since the remains of the substance after exhalation are retained by the sorbent in the deactivation chamber in the device body.

The patient can independently stop breathing through the device when the required level of anesthesia is reached. When the feeling of pain returns, the patient can independently start breathing again through the device.

After use, the medical device should be disposed of in accordance with local waste disposal requirements.

If you need additional information, please contact the YURiА-PHARM representative in your region.

You can also call 0800402022 or send your request to the email address info@uf.ua with your contact phone number and place of work so that a company representative will contact you directly.

Sources of information:

1. Keith M Porter, Anthony D Dayan, Sara Dickerson, Paul M Middleton, Published 18 October 2018 Volume 2018:10 Pages 149—164. The role of inhaled methoxyflurane in acute pain management, doi.org/10.2147/OAEM.S181222.

2. Br J Anaesth. 2018 May; 120(5):1040-1048. doi: 10.1016/j.bja.2018.01.011.

3. Дубров Сергій Олександрович, Черняєв Степан Володимирович, Метоксифлуран: історичний огляд та аналіз безпеки використання як анальгетика при невідкладних та амбулаторних процедурах. Журнал “Pain, Anaesthesia & Intensive Care”, № 3, 2024.

4. Porter KM, Dayan AD, Dickerson S, Middleton PM. The role of inhaled methoxyflurane in acute pain management. Open Access Emergency Medicine [Internet]. 2018 Oct; Volume 10:149–64. Available from: dx.doi.org/10.2147/oaem.s181222.